Visakhapatnam: India reports one of the highest numbers of eye cancer cases in the world, particularly retinoblastoma, which ...
Get Instant Summarized Text (Gist) Organoid models have been developed to study uveal melanoma, a common adult eye cancer, using patient-derived tissue to create accurate 3D models. These ...
Replimune's innovative cancer therapies, strong cash reserves, and FDA support position it to disrupt oncology markets. Click ...
The leading Advanced Melanoma Companies such as OncoSec Medical, Immunocore, Sanofi, TILT Biotherapeutics, Novartis ...
1d
Zacks.com on MSNCSTL Gears Up to Report Q4 Earnings: Here's What You Should KnowCastle Biosciences, Inc. CSTL is scheduled to report fourth-quarter and full-year 2024 results on Feb. 27, after market close ...
Prognostic significance of pigmentation and stem cell markers in Indian population of uveal melanoma
Background Increased pigmentation has been associated with cancer stem-cell-like behaviour and chemoresistance in uveal ...
India faces high burden of eye cancers, including retinoblastoma in children, with early detection crucial for successful treatment.
The updated NCCN Guidelines now include HEPZATO KIT as a Category 2A treatment option for patients with hepatic-dominant uveal melanoma. Previously, the guidelines limited its use to patients with ...
A benefit for South Lake Tahoe local Jennifer Milligin, who is recovering from Ocular Melanoma (eye cancer), will be held at ...
Shares of Castle Biosciences, Inc. (NASDAQ:CSTL – Get Free Report) have been given a consensus rating of “Buy” by the seven ...
U.S. Food and Drug Administration (FDA) recently accepted the Biologics License Application (BLA) for RP1 plus nivolumab in advanced melanoma for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results